RecruitingNot ApplicableNCT05577598

Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder


Sponsor

Medical University of Vienna

Enrollment

8 participants

Start Date

Apr 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this randomized, sham-controlled study is to evaluate the effectiveness of DBS therapy in individuals suffering from severe OCD and to investigate DBS treatment with functional \[18F\]FDG-Brain-PET.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is using a brain imaging technique (FDG-PET scan) to measure glucose (sugar) use in specific brain regions during deep brain stimulation (DBS) therapy in people with severe, treatment-resistant OCD. The goal is to understand exactly how DBS changes brain activity in OCD. **You may be eligible if...** - You have severe OCD (score of 25 or higher on the Yale-Brown OCD scale) - You have tried and failed at least two medications (serotonin reuptake inhibitors) at adequate doses and duration - You have also tried other medication augmentation strategies and cognitive-behavioral therapy - You can provide written informed consent **You may NOT be eligible if...** - You have a history of psychosis - You have significant other neurological or psychiatric conditions - You are pregnant - You cannot tolerate the imaging or surgical procedures required Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEImplantation of a DBS therapy system

The system is called "Reclaim DBS Therapy for OCD" und is marketed by Medtronic (Minneapolis, Minnesota). It has a HDE status by the FDA. The system consists of two quadripolar electrodes (Medtronic Reclaim DBS) as well as a generator (Medtronic Activa PC), which will be implanted into a subcutaneous pocket below the clavicula.


Locations(1)

Medical University of Vienna, Department of Psychiatry and Psychotherapy

Vienna, State of Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05577598


Related Trials